Integrated Diagnostics Holdings plc (FRA:8I8)

Market Cap	272.02M +27.6%
Revenue (ttm)	132.56M +36.1%
Net Income	23.10M +58.0%
EPS	0.04 +58.0%
Shares Out	n/a
PE Ratio	11.78
Forward PE	n/a
Dividend	0.02 (5.17%)
Ex-Dividend Date	May 28, 2026

Volume	n/a
Open	0.4280
Previous Close	0.4220
Day's Range	0.4280 - 0.4280
52-Week Range	0.3280 - 0.7100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 2, 2026

About FRA:8I8

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroe...

• Industry: Medical Laboratories
• Founded: 1979
• Employees: 7,137
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8I8

Financial Performance

In 2025, FRA:8I8's revenue was 7.86 billion, an increase of 37.34% compared to the previous year's 5.72 billion. Earnings were 1.26 billion, an increase of 17.15%.

Financial numbers in EGP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 25, 2026

Data Sources Report a data error